Home1SXP • ETR
add
SCHOTT Pharma AG & Co KgaA
Previous close
€31.10
Day range
€31.64 - €32.40
Year range
€25.64 - €43.40
Market cap
4.84B EUR
Avg Volume
59.63K
P/E ratio
31.59
Dividend yield
0.47%
Primary exchange
ETR
Financials
Income Statement
Revenue
Net income
| (EUR) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 253.59M | 14.56% |
Operating expense | 34.65M | -5.38% |
Net income | 46.26M | 51.75% |
Net profit margin | 18.24 | 32.46% |
Earnings per share | 0.31 | — |
EBITDA | 68.93M | 22.98% |
Effective tax rate | 16.95% | — |
Balance Sheet
Total assets
Total liabilities
| (EUR) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 22.15M | 6.00% |
Total assets | 1.40B | 21.33% |
Total liabilities | 629.73M | 25.46% |
Total equity | 769.30M | — |
Shares outstanding | 148.88M | — |
Price to book | 6.03 | — |
Return on assets | 9.50% | — |
Return on capital | 12.72% | — |
Cash Flow
Net change in cash
| (EUR) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | 46.26M | 51.75% |
Cash from operations | 57.92M | 38.02% |
Cash from investing | -24.22M | 25.80% |
Cash from financing | -30.05M | -229.21% |
Net change in cash | 3.14M | 16,615.79% |
Free cash flow | 39.58M | — |
About
Schott Pharma is a provider of drug containment solutions and delivery systems for injectable drugs. Originally a subsidiary of the glass manufacturer Otto Schott, the company went private and subsequently entered the Frankfurst Stock Exchange in 2023. Headquartered in Mainz, Germany, the company operates in 14 countries. Wikipedia
Founded
Aug 1, 2022
Website
Employees
4,681
